Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Synthetic Cannabinoids (K2 / Spice)

Are Synthetic Cannabinoids (K2 / Spice) legal in Poland?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Controlled, and by two different techniques at once. Poland names many of them individually on the narcotic annex, with JWH-015 at lp. 87, JWH-073 at lp. 90, JWH-122 at lp. 93 and AM-2201 and its relatives among the entries in the same run of group I-N. Separately, Załącznik nr 3 defines synthetic cannabinoids as a structural class, group III-NPS, by core, linker and side chain rather than by name, and the 2025 amending regulation widened that definition again by adding a 1H-indol-2-on-1,3-diyl core and a carbonylhydrazone linker. Which technique catches a given compound decides which possession provision applies to it.
Consequences if caught
Capital exposure: none. Poland has no death penalty, and the heaviest band the 2005 Act reaches for any conduct with this substance is a term of years. For a compound named in group I-N the possession provision is article 62. Possession is an offence under article 62(1) of the 2005 Act and the band there is up to three years. Where the quantity is considerable, article 62(2) sets a band of one year to ten years. In a case of lesser gravity article 62(3) provides instead for a fine, a restriction of liberty or up to one year. Article 62a lets proceedings be discontinued, even before the decision to open an investigation, where the quantity is insignificant and intended for the holder's own use and a penalty would be inexpedient. That is a power of the prosecutor and not an entitlement of the holder, so it is not decriminalisation. For a compound caught only by the group III-NPS structural definition the possession provision is article 62b instead. Possession is an offence under article 62b(1) of the 2005 Act and the penalty there is a fine. Where the quantity is considerable, article 62b(2) provides for a fine, a restriction of liberty or up to three years. Article 62b(3) lets proceedings be discontinued on the same insignificant quantity and own use test that article 62a applies to narcotics and psychotropics, again as a power and not an entitlement. The separate and lighter possession band is the practical consequence of sitting on Załącznik nr 3 rather than on Załącznik nr 1 or nr 2. Supply offences sit apart from possession. Article 56 punishes putting such a substance on the market with a fine and six months to eight years, and article 56(3) raises that to a fine and two years to twelve years where the quantity is considerable. Article 59(1) punishes supply for gain with one year to ten years. The published Poland entry described control as a class through the 2005 Act as amended in 2018 to fold former legal highs into the list. That framing is carried forward from the published Poland entry, and the two technique split read here is the more precise statement.
If prescribed or medical
There is no authorised medicinal product with this substance in Poland, so no prescription route exists for it. Article 33(1) would permit a medical use of a group I-N narcotic, and no product containing it is marketed in Poland.
Documentation
No personal import route exists, because a listed substance may be brought in only under the licensing chapter of the 2005 Act and not on a traveller's own account. The certificate issued under article 75 of the Convention implementing the Schengen Agreement is the route for a prescribed controlled medicine and does not reach a substance for which no prescription can be written. Sprayed herbal material is the usual presentation, and whether the particular compound is individually named or caught by the group III-NPS structural definition decides which possession provision applies.
Primary sources
  • Rozporządzenie Ministra Zdrowia z dnia 17 sierpnia 2018 r. w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, tekst jednolity Dz.U. 2024 poz. 1139
  • api.sejm.gov.pl
  • Rozporządzenie Ministra Zdrowia z dnia 30 kwietnia 2025 r. zmieniające to rozporządzenie, Dz.U. 2025 poz. 598, w mocy od 22 maja 2025 r.
  • api.sejm.gov.pl
  • Rozporządzenie Ministra Zdrowia z dnia 7 lipca 2026 r. zmieniające to rozporządzenie, Dz.U. 2026 poz. 934, w mocy od 28 lipca 2026 r.
  • api.sejm.gov.pl
  • Ustawa z dnia 29 lipca 2005 r. o przeciwdziałaniu narkomanii, tekst jednolity Dz.U. 2023 poz. 1939, art. 4 pkt 25 i 26, art. 31, art. 32, art. 33, art. 44f, art. 62, art. 62a, art. 62b
  • api.sejm.gov.pl
  • the regulation, both amending regulations and the Act were read at api.sejm.gov.pl on 21 September 2026

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Synthetic Cannabinoids (K2 / Spice) in related jurisdictions

Other substances confirmed in Poland

Same substance, other countries